All lobbying filings

ERVIN GRAVES STRATEGY GROUP, LLC

ERVIN GRAVES STRATEGY GROUP, LLC filed a Q1 report for N BRERETON MEDICAL TECHNOLOGIES on April 17, 2026, reporting $10,000 in lobbying income.

Lobbying for N BRERETON MEDICAL TECHNOLOGIES · Medical technology focused on pain management and opioid reduction solutions.

All filings by ERVIN GRAVES STRATEGY GROUP, LLC · Everything N BRERETON MEDICAL TECHNOLOGIES has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Alcohol and Drug Abuse

Development and use of medical technologies for pain management and opioid dependency treatment, including titration-based methodologies (FenBlock).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.